Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Bell

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Veterinary Medical Association|October 20, 1998
Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphomaC Khanna, E M Lund, K A Redic, et al.
Journal of Veterinary Internal Medicine|November 1, 1994
Response of canine mast cell tumors to treatment with oral prednisoneD L McCaw, M A Miller, G K Ogilvie, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptaseC Ahgren, K Backro, F W Bell, et al.
Journal of Medicinal Chemistry|December 8, 1995
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogsF W Bell, A S Cantrell, M Högberg, et al.
Journal of Medicinal Chemistry|July 9, 1993
Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureusR J Ternansky, S E Draheim, A J Pike, et al.
The Veterinary Clinics of North America. Small Animal Practice|May 1, 1984
Redefinition of the feline urologic syndrome: feline lower urinary tract disease with heterogeneous causesC A Osborne, G R Johnston, D J Polzin, et al.
Journal of Veterinary Internal Medicine|May 1, 1995
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disordersF W Bell, J S Klausner, D W Hayden, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Veterinary Medical Association|October 20, 1998
Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphomaC Khanna, E M Lund, K A Redic, et al.
Journal of Veterinary Internal Medicine|November 1, 1994
Response of canine mast cell tumors to treatment with oral prednisoneD L McCaw, M A Miller, G K Ogilvie, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptaseC Ahgren, K Backro, F W Bell, et al.
Journal of Medicinal Chemistry|December 8, 1995
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogsF W Bell, A S Cantrell, M Högberg, et al.
Journal of Medicinal Chemistry|July 9, 1993
Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureusR J Ternansky, S E Draheim, A J Pike, et al.
The Veterinary Clinics of North America. Small Animal Practice|May 1, 1984
Redefinition of the feline urologic syndrome: feline lower urinary tract disease with heterogeneous causesC A Osborne, G R Johnston, D J Polzin, et al.
Journal of Veterinary Internal Medicine|May 1, 1995
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disordersF W Bell, J S Klausner, D W Hayden, et al.
Pageof 2